Cardiological society of India position statement on COVID-19 and heart failure

The COVID 19 global pandemic has engulfed humanity with a huge impact on health systems across the world. Many patients develop myocardial injury which can lead to significant cardiovascular complications including HF. This will require aggressive management strategies which are evolving. Guideline directed drug therapy including ACEI/ARB/ARNI is to be continued in patients with pre-existing HF. Long-term cardiovascular effects of COVID-19 are yet to be ascertained. Protection of health care personnel from contracting the disease should be given high priority.

Abstract licence: CC BY-NC-ND

1. 10.

   Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China · 2020

2. 24.

   Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) · 2020

3. 30.

   Effectiveness of convalescent plasma therapy in severe COVID-19 patients · 2020

4. 36.
   Corrected

   Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 · 2020

36 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.